All AbMole products are for research use only, cannot be used for human consumption.
Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active.
| Molecular Weight | 204.29 |
| Formula | C11H12N2S |
| CAS Number | 14769-73-4 |
| Form | Solid |
| Solubility (25°C) | DMSO 100 mg/mL (ultrasonic) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Cristina López-Sánchez, et al. JAMA Dermatol. Levamisole-Induced Vasculopathy
[3] Noah Scheinfeld, et al. Am J Clin Dermatol. Levamisole in dermatology : a review
[4] W K Amery, et al. Int J Immunopharmacol. Levamisole, the story and the lessons
[5] No authors listed. Lancet. Levamisole--a cautionary note
| Related AChR/AChE Products |
|---|
| VU 0255035
VU 0255035 is a highly selective M1 muscarinic acetylcholine receptor (mAChR) antagonist (Ki = 14.87 nM). |
| SVT-40776
SVT-40776 is a novel M3 muscarinic receptor antagonist. |
| Aniracetam
Aniracetam is a compound that promotes intellectual development and neuroprotection. |
| Aceclidine hydrochloride
Aceclidine is a parasympathomimetic miotic agent used to decreases intraocular pressure. |
| Aclidinium Bromide
Aclidinium Bromide is a novel long-acting muscarinic antagonist that binds to the human muscarinic receptors AChR M1, M2, M3, M4, and M5 with Ki values of 0.1 nM, 0.14 nM, 0.14 nM, 0.21 nM, and 0.16 nM, respectively. It can be used in chronic obstructive pulmonary disease (COPD) studies. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
